Heron Therapeutics, INC.
​Pharmaceutical company
Based in CA
🤖
AI Overview
With $1.6M in lobbying spend across 33 quarterly filings, Heron Therapeutics, INC. is a significant lobbying presence. They deploy 12 individual lobbyists
$1.6M
Total Lobbying Spend
33
Quarterly Filings
1
Lobbying Firms Used
12
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $200K |
| 2020 | $150K |
| 2021 | $250K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Lobbying Firms
FARRAGUT PARTNERS LLP
What They Lobby For
- Issues related to opioid epidemic/specifically modifying rate setting for post surgical non opiods.
- Issues related to opioids. Medicare coverage decisions.
- Medicare coverage decisions.
- Issues related to opioid epidemic/specifically modifying rate setting for post surgical non opioids. Work on HR 5809
- Issues related to opioids-specifically modifying rate setting policies at CMS. Medicare coverage decisions.
- Issues related to opioids specifically modifying rate setting policies at CMS. Medicare coverage decisions.
- Issues related to opioids specifically modifying rate setting policies at CMS. Medicare coverage decisions. FDA guidance
- Issues related to opioids specifically modifying rate setting policies at CMS. Medicare coverage decisions. FDA guidance
- Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.